Downloaded 10 times
![Introduction & History.
• It was initially reported to the WHO on
December 31, 2019. On January 30, 2020,
the WHO declared the COVID-19 outbreak
a global health emergency. [2, 3] On March
11, 2020, the WHO declared COVID-19 a
global pandemic,](https://image.slidesharecdn.com/covid-19-221201051413-a934dad9/85/Covid-19-pptx-6-320.jpg)
Uploaded byPradeep Pande
Covid -19.pptx
This document provides tips and instructions for using a PowerPoint presentation (PPT) for active learning sessions on medical topics. The key points are: - Slides can be freely edited, modified and personalized. - Many slides will be intentionally blank except for the title to prompt student discussion of that topic. - The instructor should first show the blank slides to elicit student feedback before presenting information on subsequent slides. - This process repeats to reinforce learning over three revisions of the material. - The PPT can also be used for self-study. - Bibliographic references are included in the notes section.
More Related Content
Similar to Covid -19.pptx
More from Pradeep Pande
Covid -19.pptx
- 1. Tips on usingmy ppt. 1. You can freely download, edit, modify and put your name etc. 2. Don’t be concerned about number of slides. Half the slides are blanks except for the title. 3. First show the blank slides (eg. Aetiology ) > Ask students what they already know about ethology of today's topic. > Then show next slide which enumerates aetiologies. 4. At the end rerun the show – show blank> ask questions > show next slide. 5. This will be an ACTIVE LEARNING SESSION x three revisions. 6. Good for self study also. 7. See notes for bibliography.
- 2.
- 3. Learning Objectives 1. Introduction& History 2. Relevant Anatomy, Physiology 3. Aetiology 4. Pathophysiology 5. Pathology 6. Classification 7. Clinical Features 8. Investigations 9. Management 10. Prevention 11. Guidelines 12. Take home messages
- 4.
- 5. Introduction & History. •Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2; formerly called 2019-nCoV), • First identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China.
- 6. Introduction & History. •It was initially reported to the WHO on December 31, 2019. On January 30, 2020, the WHO declared the COVID-19 outbreak a global health emergency. [2, 3] On March 11, 2020, the WHO declared COVID-19 a global pandemic,
- 7.
- 8. Aetiology • Idiopathic • Congenital/Genetic • Nutritional Deficiency/excess • Traumatic • Infections /Infestation • Autoimmune • Neoplastic (Benign/Malignant) • Degenerative / lifestyle • Iatrogenic • Psychosomatic • Poisoning/ Toxins/ Drug induced
- 9. Aetiology • Idiopathic • Congenital/Genetic •Traumatic • Infections /Infestation • Autoimmune • Neoplastic (Benign/Malignant) • Degenerative • Iatrogenic
- 10. Aetiology • Severe acuterespiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV).
- 11.
- 12. Aetiology of Aetiology •Idiopathic • Congenital/ Genetic • Nutritional Deficiency/excess • Traumatic • Infections /Infestation • Autoimmune • Neoplastic (Benign/Malignant) • Degenerative / lifestyle • Iatrogenic • Psychosomatic • Poisoning/ Toxins/ Drug induced
- 13.
- 14. Classification • Asymptomatic • Mild81% • Severe 14% • Critical 5% – ARDS • Fatal 2.3%
- 15.
- 16. Clinical Features • Demography •Symptoms • Signs • Prognosis • Complications
- 17.
- 18. Demography • Incidence &Prevalence • Geographical distribution. • Race • Age • Sex • Socioeconomic status • Temporal behaviour
- 19. Demography • Incidence &Prevalence-
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.
- 26.
- 27. Symptoms • Presentations ofCOVID-19 have ranged from asymptomatic/mild symptoms to severe illness and mortality. • Mean incubation period to be 5.1 days 2 days to 2 weeks.
- 28. Symptoms Common • Fever • Cough •Myalgia • Fatigue Less-common • Headache • Sputum production • Diarrhea • Malaise • Shortness of breath/dyspnea • Respiratory distress
- 29. Symptoms • The mostcommon serious manifestation of COVID-19 appears to be pneumonia. • A complete or partial loss of the sense of smell (anosmia) has been reported as a potential history finding . Its clinical importance is questionable
- 30.
- 31. Signs • General Examination •Systemic Examination • Local Examination
- 32.
- 33.
- 34.
- 35.
- 36. Prognosis • Morbidity • Mortalityrate • 5 year survival in Malignancy
- 37.
- 38. Investigations • Laboratory Studies –Routine – Special • Imaging Studies • Tissue diagnosis – Cytology • FNAC – Histology – Germ line Testing and Molecular Analysis • Diagnostic Laparotomy.
- 39. Investigations • Laboratory Studies –Routine – Special • Imaging Studies • Tissue diagnosis – Cytology • FNAC – Histology
- 40.
- 41. Investigations in Malignancy •For diagnosis • For staging • For Screening • For Monitoring
- 42.
- 43. Diagnostic Studies Imaging Studies •X-Ray • USG • CT • Angiography • MRI • Endoscopy • Nuclear scan
- 44.
- 45. Management • Early Oxygensupport • No Steroids • Conservative fuid management. • Monitoring • Co- Morbidities. • Early communication • Early mechanical ventilation • No Lopinavir • Hydroxychloroquine • Azithromycin • Tocilizumab • Empiric Antibiotics
- 46. Mechanical Ventilation • Lowtidal volume 4-8ml/Kg • Low plateau pressure <30cm of water • High PEEP • Permissive hypercapnoea • Deep sedation • Prone • Target Spo2 90%
- 47.
- 48. Prevention • Screening • Riskreduction
- 49.
- 50.
- 51. Get this pptin mobile 1. Download Microsoft PowerPoint from play store. 2. Open Google assistant 3. Open Google lens. 4. Scan qr code from next slide.
- 52. Get this pptin mobile
- 53. Get my pptcollection • https://www.slideshare.net/drpradeeppande/ edit_my_uploads • https://www.dropbox.com/sh/x600md3cvj8 5woy/AACVMHuQtvHvl_K8ehc3ltkEa?dl =0 • https://www.facebook.com/doctorpradeeppa nde/?ref=pages_you_manage
Editor's Notes
- #2 drpradeeppande@gmail.com 7697305442